Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Data on tuberculosis reported by researchers at University of British Columbia
February 4th, 2009
According to recent research from Vancouver, Canada, "Recent approval of interferon-gamma release assays that arc more specific for Mycobacterium tuberculosis; has given new options for the diagnosis of latent tuberculosis infection (LTBI). To assess the cost-effectiveness of QuantiFERON (R)-TB Gold (QFT-G) vs. the tuberculin skin test (TST) in diagnosing LTBI in contacts of active TB cases using a decision analytic Markov model." "Three screening strategies-TST alone, QFT-G alone and sequential screening of TST then QFT-G-were evaluated. The model was further stratified according to ethinicity and bacille Calmette-Guerin (BCG) vaccination status. Data sources included...
Source: Vaccine Weekly (2009-02-04)
|
